Related Experiment Video
Updated: Apr 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal drug exposure affects neonatal brain functional connectivity
Andrew P Salzwedel1, Karen M Grewen2, Clement Vachet3
1Department of Radiology and Biomedical Research Imaging Center and.
Insights
Prenatal cocaine exposure (PCE) disrupts infant brain connectivity, particularly in arousal regulation networks. This study reveals early neural changes, aiding in risk identification and intervention for prenatal drug exposure effects.
Area of Science:
- Neuroscience
- Developmental Psychology
- Radiology
Background:
- Prenatal drug exposure, especially cocaine, has known neurodevelopmental consequences.
- Neural underpinnings of prenatal cocaine exposure (PCE) are poorly understood, particularly in neonates.
- Existing studies are often confounded by postnatal environmental factors.
Purpose of the Study:
- To characterize the earliest neural correlates of PCE using functional connectivity.
- To investigate the impact of PCE on amygdala and insula connectivity in neonates.
- To differentiate cocaine-specific effects from general poly-drug exposure impacts.
Main Methods:
- Utilized resting-state functional magnetic resonance imaging (fMRI) in a large neonate sample (N=152).
- Compared infants with PCE (and other drug exposures) to controls with non-cocaine poly-drug exposure and drug-free infants.
- Focused on functional connectivity within amygdala-frontal and insula-related circuits.
Main Results:
- Identified common drug exposure-related disruptions in amygdala-frontal, insula-frontal, and insula-sensorimotor circuits.
- Detected a cocaine-specific connectivity alteration within an amygdala-frontal network subregion.
- This cocaine-specific pathway is implicated in arousal regulation, found to be irregular in PCE.
Conclusions:
- Provides the earliest human-based functional evidence of PCE's neurodevelopmental impact.
- Highlights specific connectivity disruptions in neonates exposed to cocaine prenatally.
- Opens avenues for early risk identification and targeted interventions for prenatal drug exposure.
Abstract:
Prenatal drug exposure, particularly prenatal cocaine exposure (PCE), incurs great public and scientific interest because of its associated neurodevelopmental consequences. However, the neural underpinnings of PCE remain essentially uncharted, and existing studies in school-aged children and adolescents are confounded greatly by postnatal environmental factors. In this study, leveraging a large neonate sample (N = 152) and non-invasive resting-state functional magnetic resonance imaging, we compared human infants with PCE comorbid with other drugs (such as nicotine, alcohol, marijuana, and antidepressant) with infants with similar non-cocaine poly drug exposure and drug-free controls. We aimed to characterize the neural correlates of PCE based on functional connectivity measurements of the amygdala and insula at the earliest stage of development. Our results revealed common drug exposure-related connectivity disruptions within the amygdala-frontal, insula-frontal, and insula-sensorimotor circuits. Moreover, a cocaine-specific effect was detected within a subregion of the amygdala-frontal network. This pathway is thought to play an important role in arousal regulation, which has been shown to be irregular in PCE infants and adolescents. These novel results provide the earliest human-based functional delineations of the neural-developmental consequences of prenatal drug exposure and thus open a new window for the advancement of effective strategies aimed at early risk identification and intervention.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Related Concept Videos
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Factors Affecting Drug Response: Overview